These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 36168737)
41. Competition between lysogenic and sensitive bacteria is determined by the fitness costs of the different emerging phage-resistance strategies. Rendueles O; de Sousa JAM; Rocha EPC Elife; 2023 Mar; 12():. PubMed ID: 36975200 [TBL] [Abstract][Full Text] [Related]
42. Phage Morons Play an Important Role in Pseudomonas aeruginosa Phenotypes. Tsao YF; Taylor VL; Kala S; Bondy-Denomy J; Khan AN; Bona D; Cattoir V; Lory S; Davidson AR; Maxwell KL J Bacteriol; 2018 Nov; 200(22):. PubMed ID: 30150232 [TBL] [Abstract][Full Text] [Related]
43. Historical Contingency Drives Compensatory Evolution and Rare Reversal of Phage Resistance. Debray R; De Luna N; Koskella B Mol Biol Evol; 2022 Sep; 39(9):. PubMed ID: 35994371 [TBL] [Abstract][Full Text] [Related]
44. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy. Fujiki J; Nakamura K; Nakamura T; Iwano H Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958612 [TBL] [Abstract][Full Text] [Related]
45. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria. Hasan M; Ahn J Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884169 [TBL] [Abstract][Full Text] [Related]
47. Parallel evolution of Castledine M; Padfield D; Sierocinski P; Soria Pascual J; Hughes A; Mäkinen L; Friman VP; Pirnay JP; Merabishvili M; de Vos D; Buckling A Elife; 2022 Feb; 11():. PubMed ID: 35188102 [TBL] [Abstract][Full Text] [Related]
48. The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination. Ferran AA; Lacroix MZ; Gourbeyre O; Huesca A; Gaborieau B; Debarbieux L; Bousquet-Mélou A Microbiol Spectr; 2022 Oct; 10(5):e0287422. PubMed ID: 36135376 [TBL] [Abstract][Full Text] [Related]
49. Hot spots become cold spots: coevolution in variable temperature environments. Duncan AB; Dusi E; Jacob F; Ramsayer J; Hochberg ME; Kaltz O J Evol Biol; 2017 Jan; 30(1):55-65. PubMed ID: 27711983 [TBL] [Abstract][Full Text] [Related]
50. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776 [TBL] [Abstract][Full Text] [Related]
51. Characterisation of broad-spectrum phiKZ like jumbo phage and its utilisation in controlling multidrug-resistant Pseudomonas aeruginosa isolates. Rai P; Shetty SS; Prabell S; Kuntar A; Pinto D; Kumar BK; Divyashree M; Raj JRM; Premanath R; Deekshit VK; Karunasagar I; Karunasagar I Microb Pathog; 2022 Nov; 172():105767. PubMed ID: 36096457 [TBL] [Abstract][Full Text] [Related]
52. Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa. Ong SP; Azam AH; Sasahara T; Miyanaga K; Tanji Y J Biosci Bioeng; 2020 Jun; 129(6):693-699. PubMed ID: 32107153 [TBL] [Abstract][Full Text] [Related]
53. Decay and damage of therapeutic phage OMKO1 by environmental stressors. Blazanin M; Lam WT; Vasen E; Chan BK; Turner PE PLoS One; 2022; 17(2):e0263887. PubMed ID: 35196336 [TBL] [Abstract][Full Text] [Related]
54. Mutant and Recombinant Phages Selected from Peters TL; Song Y; Bryan DW; Hudson LK; Denes TG Appl Environ Microbiol; 2020 Oct; 86(22):. PubMed ID: 32887717 [TBL] [Abstract][Full Text] [Related]
55. Combination of genetically diverse Pseudomonas phages enhances the cocktail efficiency against bacteria. Naknaen A; Samernate T; Wannasrichan W; Surachat K; Nonejuie P; Chaikeeratisak V Sci Rep; 2023 Jun; 13(1):8921. PubMed ID: 37264114 [TBL] [Abstract][Full Text] [Related]
56. Network structure and local adaptation in co-evolving bacteria-phage interactions. Gurney J; Aldakak L; Betts A; Gougat-Barbera C; Poisot T; Kaltz O; Hochberg ME Mol Ecol; 2017 Apr; 26(7):1764-1777. PubMed ID: 28092408 [TBL] [Abstract][Full Text] [Related]
57. Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms. Zhang QG; Buckling A Evol Appl; 2012 Sep; 5(6):575-82. PubMed ID: 23028398 [TBL] [Abstract][Full Text] [Related]
58. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480 [TBL] [Abstract][Full Text] [Related]
59. Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University. Würstle S; Lee A; Kortright KE; Winzig F; An W; Stanley GL; Rajagopalan G; Harris Z; Sun Y; Hu B; Blazanin M; Hajfathalian M; Bollyky PL; Turner PE; Koff JL; Chan BK Sci Rep; 2024 Feb; 14(1):2657. PubMed ID: 38302552 [TBL] [Abstract][Full Text] [Related]
60. Resistance Evolution against Phage Combinations Depends on the Timing and Order of Exposure. Wright RCT; Friman VP; Smith MCM; Brockhurst MA mBio; 2019 Sep; 10(5):. PubMed ID: 31551330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]